title: Resident Rounds. Part III B: tumor necrosis factor-α antagonists and alopecia areata: a class-wide adverse effect.
authors.affiliation: School od Medicine, University of Mississipi, Jackson, MS, USA.
authors.forename: James L
authors.initials: JL
authors.lastname: Griffith
authors.forename: Johnathan J
authors.initials: JJ
authors.lastname: Ledet
authors.forename: Boni E
authors.initials: BE
authors.lastname: Elewski
mesh_terms: D000506:Alopecia Areata / Q000139:chemically induced*; D015535:Arthritis, Psoriatic / Q000188:drug therapy; D000068800:Etanercept; D005500:Follow-Up Studies; D006801:Humans; D007074:Immunoglobulin G / Q000009:adverse effects* / Q000627:therapeutic use; D007155:Immunologic Factors / Q000009:adverse effects* / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy; D018124:Receptors, Tumor Necrosis Factor / Q000627:therapeutic use; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors*
chemical_list: D007074:Immunoglobulin G; D007155:Immunologic Factors; D018124:Receptors, Tumor Necrosis Factor; D014409:Tumor Necrosis Factor-alpha; D000068800:Etanercept